The Midlife
Hero pillar · Perimenopause guide

Perimenopause
in Australia.

A science-literate walk through STRAW+10 staging, AU clinical context, the top 12 symptoms ranked by what AU women actually search for, and the supplements with the strongest peer-reviewed evidence at each stage.

By The Midlife Editorial Team Updated 8 May 2026
Editorial portrait — Australian woman in her early 50s seated at a sunlit writing desk reading research, slim tortoiseshell glasses, charcoal merino, eucalyptus on the desk
TL;DR

Perimenopause is the 4–10-year transition leading to your final menstrual period (FMP) — it ends 12 months after the FMP. The international clinical staging system is STRAW+10, with 10 stages defined by measurable biomarker shifts (FSH, AMH, oestradiol). Most AU consumer content collapses these stages. We don't. Below: what each stage looks like, what symptoms map where, when to see your GP, and which supplements have peer-reviewed evidence at each point.

What is perimenopause?

Perimenopause means "around menopause" — the hormonal transition that begins in the late reproductive years and ends 12 months after the final menstrual period (FMP). For most Australian women, perimenopause begins around the late 30s to mid-40s and lasts 4–10 years, though the range is wider than most consumer content suggests.

It is not a single event. Oestrogen does not "drop" smoothly. Across perimenopause, the variability in cycle length, follicle stimulating hormone (FSH), anti-Müllerian hormone (AMH), inhibin B, and oestradiol becomes the defining clinical signal — not absolute levels at any one moment. This matters because a single blood test can look "normal" in early perimenopause even when symptoms are very real.

2. The STRAW+10 staging system

The international clinical reference for staging female reproductive ageing is STRAW+10 — the Stages of Reproductive Aging Workshop +10 update, published 20121. The Australasian Menopause Society's 2025 Practitioner's Toolkit aligns with STRAW+102.

The 10 stages run from late reproductive (stage –3b) through the final menstrual period (stage 0) into late post-menopause (stage +2). The four primary biomarkers are FSH, AMH, inhibin B, and oestradiol — AMH is typically the first to change, followed by FSH and inhibin B, with oestradiol declining in late menopausal transition.

Stage Name What's happening Median age
–3bLate reproductiveCycles regular; AMH ↓, AFC ↓early 40s
–3aLate reproductive (subtle change)Slight cycle shortening; FSH variablemid 40s
–2Early MT (perimenopause begins)Cycle-length variability ≥7 days~47
–1Late MT≥60-day amenorrhoea episodes~49–50
0Final menstrual period (FMP)Defined retrospectively, 12 months later~51
+1a/bEarly post-meno yr 1–2FSH ↑, oestradiol stabilising low51–53
+1cEarly post-meno yr 3–6Vasomotor symptoms peak then taper53–57
+2Late post-menoGenitourinary syndrome (GSM) often emerges57+

Why this matters editorially: if you read "supplements for menopause" without a stage attached, the advice is averaged across 20 years of biology. We tag every protocol on this site to the STRAW+10 stage where its evidence is strongest.

3. The top 12 symptoms — ranked

Synthesised from AMS clinical sources, Jean Hailes resources, and primary-source community feedback (Reddit's r/Menopause 2025–2026, AU Facebook groups). Ordered by combined search volume + community discussion intensity.

  1. Sleep disruption / 3am wake-ups. Cortisol awakening + falling progesterone (a GABA-A agonist). The most-searched perimenopause query pattern in Australia. Full protocol →
  2. Anxiety / panic / sense of dread. Falling oestrogen → serotonin dysregulation. Often the first symptom to appear and the one that GPs most commonly miss.
  3. Weight changes that don't respond. Insulin sensitivity shifts; muscle loss accelerates without resistance training. Old strategies stop working.
  4. Brain fog / memory. Oestrogen receptor density shifts in the hippocampus. The CONCRET-MENOPA trial associated 1,500 mg creatine HCL daily with reaction-time and frontal-brain-creatine improvements3.
  5. Hot flushes / vasomotor symptoms. Hypothalamic thermoregulation disruption. MHT is the most effective treatment per AMS2.
  6. Mood swings / rage / inexplicable sadness. Oestrogen × dopamine/serotonin volatility.
  7. Joint pain / arthralgia. Oestrogen receptors in joint cartilage. Anti-inflammation category →
  8. Fatigue / unrelenting exhaustion. Get an iron screen at the GP first.
  9. Heavy / irregular bleeding. Anovulatory cycles — review with GP, rule out other causes.
  10. Digestive changes / bloat. Gut motility shifts; food sensitivities can emerge.
  11. Libido / sexual dysfunction. Falling oestrogen + testosterone. Vaginal oestrogen and testosterone are clinician-only conversations.
  12. Skin / hair changes. Falling oestrogen affects collagen production and follicles.

4. When to see your GP — non-negotiable

This site is editorial. It is not medical advice. Some symptoms need a clinician, not a supplement. See your GP if you have:

  • Heavy or prolonged bleeding (more than 7 days, or flooding through a sanitary product within an hour)
  • Bleeding after sex, between periods, or after 12 months without a period
  • Persistent depressive thoughts or thoughts of self-harm
  • A personal or family history of hormone-sensitive cancer if you are considering MHT
  • Suspected sleep apnoea (loud snoring, daytime fatigue despite long sleep)

The Australasian Menopause Society maintains a find-a-doctor directory of AU clinicians with a special interest in menopause.

5. Lifestyle levers (the part that's not in a bottle)

Before any supplement, these are the levers with the strongest evidence base in midlife:

  • Resistance training, 2–3 sessions per week. Combined with creatine, supports lean mass, bone density, and cognition4.
  • Sleep hygiene: cool room, no alcohol within 3 hours of bed, no screens 30 minutes before bed, morning sunlight within an hour of waking.
  • Cutting alcohol — perhaps the single biggest under-discussed lever. Alcohol sensitivity rises in perimenopause; sleep architecture is hit hardest.
  • Protein, ~1.6 g/kg/day across midlife. The AMS-aligned target supports muscle preservation against sarcopenia.
  • Social connection. Sounds soft; the longitudinal evidence on inflammation and longevity in midlife women is hard.

6. Supplements with the strongest evidence in midlife

Short summary — full protocol-led detail on the midlife supplement stack pillar.

7. About MHT (menopausal hormone therapy)

MHT — also called HRT — is the most effective treatment for moderate-to-severe vasomotor symptoms per the Australasian Menopause Society2. It is a prescription medical decision that must be made between you and your treating doctor.

This site does not prescribe MHT. We refer. The AMS publishes a current AU MHT/HRT Doses Guide (November 2024) and a Practitioner's Toolkit (2025) — both are designed for clinicians but accessible to motivated readers.

8. AU regulatory context — what TGA lets brands say

Listed complementary medicines in Australia must be registered on the Australian Register of Therapeutic Goods (ARTG) with an AUST L number before supply. Listed medicines may only use indications drawn from the pre-approved permitted-indications list (currently 778 indications under the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025).

What this means for you as a reader: the language allowed on a supplement label in Australia is more conservative than what you see in US marketing. A brand cannot legally claim to "treat" or "cure" perimenopause symptoms — only to "support" or "may help maintain" certain functions. We mirror that language on this site.

9. Frequently asked questions

What's the difference between perimenopause and menopause?

Perimenopause is the transition leading up to menopause. Menopause is technically a single point in time — the moment 12 months after your final menstrual period. After that point, you are post-menopausal.

How long does perimenopause last?

Typically 4–6 years, but the full range observed is 1–10 years. The variability is real and normal.

What is STRAW+10?

The Stages of Reproductive Aging Workshop +10 — the international clinical staging system for female reproductive ageing, published 2012 and the basis of the AMS 2025 Practitioner's Toolkit.

What is the median age of menopause in Australia?

Approximately 51, in line with international averages. Earlier menopause (before 40) is termed primary ovarian insufficiency (POI) and warrants specific clinical follow-up.

Where do I find an AU women's-health GP?

The AMS maintains a find-a-doctor directory. Telehealth services like WellFemme are also AU-based and women's-health-specialised.

References

  1. Harlow SD et al., 2012. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. PMID 22399517.
  2. Australasian Menopause Society. Practitioner's Toolkit for the Management of the Menopause (2025 update). menopause.org.au.
  3. 2025 RCT (CONCRET-MENOPA). The effects of 8-week creatine HCL on cognition, clinical outcomes and brain creatine levels in perimenopausal and menopausal women. J Am Nutr Assoc. PMID 40854087.
  4. Hall et al., 2025. Creatine and resistance training in peri- and postmenopausal women. PMC12291186.

Editorial note: this guide is updated as new AU clinical guidance and peer-reviewed evidence is published. Last refreshed 8 May 2026. We use "supports / may help / is associated with" language by editorial discipline — never "treats / cures / prevents". Content is for general information only and is not medical advice. Always consult your GP or a qualified Australian practitioner before changing your supplement, training or hormone-therapy routine.